Research
Broad genomic testing linked to longer survival in advanced lung cancer, according to new study
The Brief
- A study in the November 2026 issue of the Journal of the National Comprehensive Cancer Network found that patients with advanced non-small cell lung cancer lived longer when they received broad-based genomic sequencing (BGS).
- BGS tests a large panel of dozens or hundreds of genes at once.
- The reported finding is an association between broad genomic testing and longer survival.
Why it matters
It suggests that broad genomic profiling may be linked to better outcomes for patients with advanced lung cancer, which bears on how clinicians choose molecular testing.
Who’s affected
- oncologists and lung cancer clinicians
- patients with advanced non-small cell lung cancer
- #lung cancer
- #genomics
- #oncology
- #survival
- #sequencing
New research in the November 2026 issue of Journal of the National Comprehensive Cancer Network found that patients with advanced non-small cell lung cancer (NSCLC) lived longer when they received broad-based genomic sequencing (BGS)—testing a large panel of dozens or hundreds of…